<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>02.  Department of Chemistry</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/254</link>
<description/>
<pubDate>Sun, 10 May 2026 16:06:46 GMT</pubDate>
<dc:date>2026-05-10T16:06:46Z</dc:date>
<item>
<title>Synthesis, Characterization and Biological Evaluation of Ethyl-4'-(cyclopropane carboxamido-N-yl)-5-ary-3-oxo-3,4,5,6- tetrahydro-biphenyl-4-carboxylate</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/2205</link>
<description>Synthesis, Characterization and Biological Evaluation of Ethyl-4'-(cyclopropane carboxamido-N-yl)-5-ary-3-oxo-3,4,5,6- tetrahydro-biphenyl-4-carboxylate
Akbari, P.M; Shah, V.R.
A series of new substituted cyclohexenone derivatives have been&#13;
synthesized by the reaction of various substituted chalcones with&#13;
ethylacetoacetate. Some new N-(4-(3-aryl-acryloyl)phenyl)cyclopropane&#13;
carboxamide were prepared by Claisen-Schmidt condensation&#13;
method in presence of sodium hydroxide in ethanol solvent under&#13;
stirring. The synthesized compounds were characterized by their&#13;
spectral (IR, NMR, Mass) data and screened for their antimicrobial&#13;
activities against Gram-positive and Gram-negative bacteria by using&#13;
standard antimicrobial drugs.
</description>
<pubDate>Tue, 01 Jan 2019 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://10.9.150.37:8080/dspace//handle/atmiyauni/2205</guid>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Synthesis, Characterization and in vitro Antimicrobial Evaluation of Pyrazole Based Oxothiazolidine Hybrids</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/2194</link>
<description>Synthesis, Characterization and in vitro Antimicrobial Evaluation of Pyrazole Based Oxothiazolidine Hybrids
Sanghani, Yogesh J.; Koradiya, Suresh B.; Jilariya, Krushnakumar J.
In this work, pyrazole based oxothiazolidine hybrids, 4-{4-[2-(1-&#13;
phenyl-3-(substituted)phenyl-1H-pyrazol-4-yl)-4-oxo-thiazolidin-3-&#13;
yl]-phenyl}-morpholin-3-one (11a-l) were synthesized using molecular&#13;
hybridization approach through Vilsmeier-Haack reaction. The titled&#13;
compounds 11a-l were characterized by using elemental analysis, IR,&#13;
1H NMR and mass spectral studies. The antibacterial activity of 11a-l&#13;
was evaluated in vitro by agar cup plate method against B. cocous, B.&#13;
subtillis, E. coli and P. vulgaris. The antifungal activity of compounds&#13;
11a-l was evaluated in vitro by agar based disk diffusion method&#13;
against A. niger. The results of antibacterial and antifungal evaluation&#13;
were reported in terms of zone of inhibition measured in mm. The&#13;
synthesized compounds 11a-l exhibited moderate to good antibacterial&#13;
and antifungal potential. Compound 4-{4-[2-(1-phenyl-3-(2-methoxyphenyl)&#13;
phenyl-1H-pyrazol-4-yl)-4-oxo-thiazolidin-3-yl]-phenyl}-&#13;
morpholin-3-one (11h) emerged as a most potent antimicrobial agent&#13;
displaying zone of inhibition 21, 20, 21, 24 and 20 mm against B.&#13;
cocous, B. subtillis, E. coli, P. vulgaris and A. niger, respectively.
</description>
<pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://10.9.150.37:8080/dspace//handle/atmiyauni/2194</guid>
<dc:date>2020-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Steroid and fatty acid contents from  the leaves of Carica Papaya</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/990</link>
<description>Steroid and fatty acid contents from  the leaves of Carica Papaya
Devmurari, Vishvraj V.; Patel, Poojaben P.; Jadeja, Rajeshreeba A.; Bhadaniya, Cameykumari P.; Aghara, Priti P.; Patel, Anilkumar S.; Tala, Satishkumar D.; Savant, Mahesh M.; Ladva, Kartik D.; Nariya, Pankajkumar B.
Aim: To extract and identify the non-polar entities from the leaves of Carica papaya, a plant used for medicinal purpose as folk medicine.&#13;
Materials and methods: Petroleum ether extract of the Carica papaya leaves was used for this study. Saponification process and &#13;
methylation process was performed to separate fatty acids and unsaponifiable matters. Phytochemical constituents were separated using &#13;
chemical process and separated fractions were analyzed by thin layer chromatography (TLC) and gas chromatography coupled with &#13;
mass spectroscopy (GC-MS).&#13;
Results: The chemical composition of the steroids, triterpenoids and fatty acid methyl esters (FAMEs) in leaves of Carica papaya, &#13;
which were analyzed by gas chromatography coupled with mass spectroscopy (GC-MS). A total of 15 fatty acid components were &#13;
identified in saponifiable matter, from unsaponifiable portion 2 steroids (campesterol, β- or γ-sitosterol), 1 triterpene (squalene), and 1 &#13;
diterpene (phytol) were identified.&#13;
Conclusions: The results indicate that the extract is rich in non-polar compounds. In this study, GC-MS method is at the central focus &#13;
for identification of these phytoconstituents. The current method can be used for direct analysis of non-polar entities of plant material.
We are grateful to the Department of Chemistry, Atmiya &#13;
University and Shri M. &amp; N. Virani Science College, Rajkot &#13;
for providing laboratory and other required facilities.
</description>
<pubDate>Wed, 30 Jun 2021 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://10.9.150.37:8080/dspace//handle/atmiyauni/990</guid>
<dc:date>2021-06-30T00:00:00Z</dc:date>
</item>
<item>
<title>Isolation, identification and characterization of degradation  impurity of atorvastatin in fixed dose combination of atorvastatin  and ezetimibe</title>
<link>http://10.9.150.37:8080/dspace//handle/atmiyauni/870</link>
<description>Isolation, identification and characterization of degradation  impurity of atorvastatin in fixed dose combination of atorvastatin  and ezetimibe
Desai, Rajesh; Koradiya, Suresh
The objective of this study is to isolation and characterization of unknown degradation product of Atorvastatin &#13;
calcium in combination formulation product with Ezetimibe by using modern techniques of separation and &#13;
characterization. An unknown impurity is generating during a forced degradation study of Atorvastatin and &#13;
Ezetimibe fixed-dose combination tablets. By using the gradient reversed-phase high-pressure liquid &#13;
chromatographic method, unknown degradation impurity was detected and quantified in the range of 0.05% to 0.2% &#13;
of Atorvastatin. The impurity was enriched by extreme oxidation degradation of Atorvastatin and isolated through &#13;
preparative HPLC. The structure of the impurity was characterized by mass and NMR spectrum.
</description>
<pubDate>Tue, 01 Jan 2019 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://10.9.150.37:8080/dspace//handle/atmiyauni/870</guid>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
